Danaher Corporation (DHR) Financials

DHR Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 83.4 billion 30.0 billion
2023-12-31 84.5 billion 31.0 billion
2023-09-30 87.7 billion 35.3 billion
2023-06-30 84.9 billion 33.2 billion

DHR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 1.4 billion 60.0 million
2023-12-31 1.2 billion 26.0 million
2023-09-30 1.3 billion 92.0 million
2023-06-30 1.6 billion 109.0 million

DHR Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-03-31 1.1 billion
2023-12-31 536.0 million
2023-09-30 1.1 billion
2023-06-30 1.1 billion

DHR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 7.0 billion - -
2023-12-31 5.9 billion - 1.1 billion
2023-09-30 12.3 billion 19.5 billion -
2023-06-30 8.6 billion 18.3 billion -

DHR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 748.6 million
2023-12-31 746.1 million
2023-09-30 745.9 million
2023-06-30 744.7 million

DHR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 291.0 million 368.0 million 1.8 billion -
2023-12-31 402.0 million 239.0 million 766.0 million -
2023-09-30 365.0 million 417.0 million 2.1 billion -
2023-06-30 341.0 million 418.0 million 2.2 billion -

DHR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 3.5 billion 2.3 billion
2023-12-31 2.7 billion 1.1 billion
2023-09-30 6.9 billion 2.9 billion
2023-06-30 7.2 billion 3.1 billion

DHR

List: Contenders

Price: $245.80

52 week price:
181.70
259.00

Dividend Yield: 0.43%

5-year range yield:
0.26%
0.52%

Forward Dividend Yield: 0.43%

Payout Ratio: 19.08%

Payout Ratio Range:
2.29%
19.08%

Dividend Per Share: 1.08 USD

Earnings Per Share: 5.66 USD

P/E Ratio: 43.44

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 1.8 million

Ebitda: 1.3 billion

Market Capitalization: 187.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 32

DGR3: 13.97%

DGR5: 12.03%

DGR10: 30.00%

DGR20: 30.00%

Links: